CONTREFACONS
Thursday, November 26, 2026 16:30 to 18:00 Aden services Office: 3-4/F, A Building, Modern Tower, No.218 Xiangyang South Road, Xuhui District, Shanghai 200031, China. 中国上海市徐汇区襄阳南路218号现代大厦A座3-4楼, 邮编: 200031
Price: Free
Thursday, November 26, 2026 16:30 to 18:00
Scan and Share
Benoit Raoult
Benoit Raoult
For those who are less familiar with the French Healthcare Alliance:
For further information, please consult the FHA’s website : www.french-healthcare-alliance.cn
Detail
13916407938
event@french-healthcare-alliance.cn
Views: 21

While the presence of substandard and falsified medical products (SFMPs) appears to be declining overall in the Chinese market, the problem has not disappeared. Instead, it is evolving, taking new forms and creating new risks.
This conference will provide practical insights into recent developments and the measures being taken to address these challenges. Following an overview of key definitions and the regulatory framework in China, we will examine the role and actions of Chinese Customs in combating illicit pharmaceutical products. Representatives from two pharmaceutical companies will also share their firsthand experiences and perspectives.
Nicolas Duthilleul
Customs Counsellor (East Asia), French Customs, Embassy of France in China
Antoine Thissandier
Regional Intellectual Property Adviser, INPI, Embassy of France in China
Loic Frouart
Head of Security APAC, Sanofi
Wilfrid Rogé
Head of Anti-Counterfeiting, Trademarks and Anti-Counterfeiting Department, Servier
Show Detail
Hide Detail
For those who are less familiar with the French Healthcare Alliance:
For further information, please consult the FHA’s website : www.french-healthcare-alliance.cn
Powered by Yoopay
www.yoopay.cn
400.0697.118